Spanish Lung Cancer Group   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Barcelona Spain (1991)

Organization Overview

First Clinical Trial
1998
NCT00037713
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

spanish Lun Cancer Group | Spanish Lung Cancer Group